- Home
- PHVS vs CCS Comparison
PHVS vs CCS Comparison
Compare PHVS & CCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHVS
- CCS
- Stock Information
- Founded
- PHVS 2015
- CCS 2000
- Country
- PHVS Switzerland
- CCS United States
- Employees
- PHVS N/A
- CCS N/A
- Industry
- PHVS Biotechnology: Pharmaceutical Preparations
- CCS Homebuilding
- Sector
- PHVS Health Care
- CCS Consumer Discretionary
- Exchange
- PHVS Nasdaq
- CCS Nasdaq
- Market Cap
- PHVS 1.6B
- CCS 1.7B
- IPO Year
- PHVS 2021
- CCS 2014
- Fundamental
- Price
- PHVS $24.95
- CCS $64.33
- Analyst Decision
- PHVS Buy
- CCS Buy
- Analyst Count
- PHVS 7
- CCS 5
- Target Price
- PHVS $37.00
- CCS $80.75
- AVG Volume (30 Days)
- PHVS 282.9K
- CCS 307.2K
- Earning Date
- PHVS 11-12-2025
- CCS 10-22-2025
- Dividend Yield
- PHVS N/A
- CCS 1.82%
- EPS Growth
- PHVS N/A
- CCS N/A
- EPS
- PHVS N/A
- CCS 6.93
- Revenue
- PHVS N/A
- CCS $4,157,669,000.00
- Revenue This Year
- PHVS N/A
- CCS N/A
- Revenue Next Year
- PHVS N/A
- CCS $8.74
- P/E Ratio
- PHVS N/A
- CCS $9.19
- Revenue Growth
- PHVS N/A
- CCS N/A
- 52 Week Low
- PHVS $11.51
- CCS $50.42
- 52 Week High
- PHVS $26.33
- CCS $95.76
- Technical
- Relative Strength Index (RSI)
- PHVS 57.14
- CCS 62.12
- Support Level
- PHVS $23.76
- CCS $55.99
- Resistance Level
- PHVS $26.20
- CCS $61.13
- Average True Range (ATR)
- PHVS 1.77
- CCS 1.84
- MACD
- PHVS 0.19
- CCS 0.51
- Stochastic Oscillator
- PHVS 75.19
- CCS 99.05
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About CCS Century Communities Inc.
Century Communities Inc is engaged in the development, design, construction, marketing, and selling of single-family attached and detached homes. It has five homebuilding segments: West, Mountain, Texas, Southeast, and Century Complete. Its sixth reportable segment is financial services operations, which provides mortgage, title, and insurance services to homebuyers. It has acquired land for homebuilding operations with the primary intent to develop and construct single-family detached or attached homes for sale on the acquired land. The company sells homes through its sales representatives and independent real estate brokers. The company generates the majority of its revenue from the Mountain segment.